From The
Stage

Expert perspectives focused on the latest bioanalytical topic & trends
Gene Therapy for Cancer Treatment Concept Cancer therapy with T-cell and DNA

The FDA’s Response to an Increase in the Development of Gene and Cell Therapies: What It Means for Sponsors

The FDA has observed an unprecedented increase in the number of cell and gene therapy products entering the early stages of development. In a recent statement, the agency outlined new planned policies to help accelerate these innovations through the pipeline to clinical success. We discuss what this announcement means to sponsors.

Read More »

Speak To A Scientist






    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.